newsfilter
← Latest News
GlobeNewswire·

Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference

STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), a health insights company, today announced the company will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco.